ENUM .0068 **CHEAP**Major Cancer Company, Enumeral Biomedical Holdings, Inc., a biopharmaceutical company, engages in discovering and developing antibody immunotherapies that help the immune system fight cancer and other diseases. It is developing two antagonist PD-1 antibodies, such as ENUM 388D4 and ENUM 244C8 for use in treating cancer. The company is also developing antibody drug candidates for various immunomodulatory protein targets, including TIM-3, CD39, and TIGIT. Enumeral Biomedical Holdings, Inc. has collaboration agreements with Merck Sharp & Dohme Corp.; and The University of Texas MD Anderson Cancer Center, as well as a research contract with the National Cancer Institute. Enumeral Biomedical Holdings, Inc. was founded in 2009 and is based in Cambridge, Massachusetts.
Everything I say is in my opinion, do your own DD and make your decision wisely! Don't spend more then you can afford to lose!